Author: Kon, Zachary N.; Smith, Deane E.; Chang, Stephanie H.; Goldenberg, Ronald M.; Angel, Luis F.; Carillo, Julius A.; Geraci, Travis C.; Cerfolio, Robert J.; Montgomery, Robert A.; Moazami, Nader; Galloway, Aubrey C.
Title: Extracorporeal Membrane Oxygenation Support in Severe COVID-19 Cord-id: zwu1h60j Document date: 2020_7_17
ID: zwu1h60j
Snippet: Abstract: Background Coronavirus disease 2019 (Covid-19) remains a worldwide pandemic with a high mortality rate among patients requiring mechanical ventilation. The limited data that exists regarding the utility of extracorporeal membrane oxygenation (ECMO) in these critically ill patients shows poor overall outcomes. This paper describes our institutional practice regarding the application and management of ECMO support for patients with Covid-19 and reports promising early outcomes. Methods A
Document: Abstract: Background Coronavirus disease 2019 (Covid-19) remains a worldwide pandemic with a high mortality rate among patients requiring mechanical ventilation. The limited data that exists regarding the utility of extracorporeal membrane oxygenation (ECMO) in these critically ill patients shows poor overall outcomes. This paper describes our institutional practice regarding the application and management of ECMO support for patients with Covid-19 and reports promising early outcomes. Methods All critically ill patients with confirmed Covid-19 evaluated for ECMO support from March 10th, 2020-April 24th, 2020 were retrospectively reviewed. Patients were selected for ECMO support based on a PaO2/FiO2 (P/F) ratio<150 mmHg OR pH<7.25 with a pCO2>60 mmHg with no life-limiting comorbidities. Patients were cannulated at bedside and were managed with protective lung ventilation, early tracheostomy, bronchoscopies and proning as clinically indicated. Results Of 321 patients intubated for Covid-19, 77 (24%) patients were evaluated for ECMO support with 27 (8.4%) patients placed on ECMO. All patients were placed on veno-venous ECMO. Current survival is 96.3%, with only one mortality to date in over 350 days of total ECMO support. Thirteen patients (48.1%) remain on ECMO support, while 13 patients (48.1%) have been successfully decannulated. Seven patients (25.9%) have been discharged from the hospital. Six patients (22.2%) remain in the hospital of which four are on room-air. No healthcare workers that participated in ECMO cannulation developed symptoms of or tested positive for Covid-19. Conclusions The early outcomes presented here suggest that the judicious use of ECMO support in severe Covid-19 may be clinically beneficial.
Search related documents:
Co phrase search for related documents- acute kidney injury and adequate tissue perfusion: 1
- acute kidney injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute kidney injury and lung patient: 1, 2, 3, 4, 5, 6
- acute kidney injury and lung recovery: 1, 2
- acute kidney injury and lung ventilation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute kidney injury and lung ventilation strategy: 1
- additional patient and lung injury: 1, 2, 3, 4
- additional patient and lung patient: 1, 2, 3, 4, 5, 6, 7, 8, 9
- additional patient and lung recovery: 1
- additional patient and lung ventilation: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date